COVID-19 Archives - Page 6 of 6

As clinics buzz about coronavirus, COVID19 patient given non-FDA-approved exosomes?

March 26, 2020 / Professor Paul Knoepfler, Ph.D. / 4 Comments

Kimera-Labs-exosomes-COVID-19-novel-coronavirus-disease

When the number of stem cell clinical studies and trials listed for COVID-19 first started spiraling upward it seemed likely that stem cell clinics and other firms in that arena would get interested. I thought that we’d see the unproven regenerative medicine coronavirus bandwagon quickly grow. Unfortunately, there are reasons to be increasingly concerned here. For instance, […]

As clinics buzz about coronavirus, COVID19 patient given non-FDA-approved exosomes? Read More »

Patient Q&A#2: Are autoimmune or stem cell transplant patients at higher risk from COVID-19?

March 18, 2020 / Professor Paul Knoepfler, Ph.D. / 4 Comments

I’m continuing my stem cell patient Q&A series and today’s Q&A#2 post is focused on whether autoimmune patients generally or specifically those who have received chemo and hematopoietic stem cell transplants (HSCT) are at higher risk from COVID-19? Multiple patients have asked me this. It’s a great question and obviously urgent right now during the

Patient Q&A#2: Are autoimmune or stem cell transplant patients at higher risk from COVID-19? Read More »

Athersys & Mesoblast stem cells for COVID-19?

March 10, 2020 / Professor Paul Knoepfler, Ph.D. / 7 Comments

Could two stem cell biotechs Athersys and Mesoblast help in the battle against the novel coronavirus disease COVID-19? Stem cells, ARDS, and COVID-19 I’ve already written two pieces about the idea of using stem cells to battle COVID-19 (here and here), the sometimes fatal disease that arises from infection with the novel coronavirus. Older patients

Athersys & Mesoblast stem cells for COVID-19? Read More »

‘We Cannot Stick to the Rules’: claims of stem cells saving COVID-19 patients

March 3, 2020 / Professor Paul Knoepfler, Ph.D. / 13 Comments

I’ve been watching as the number of registered stem cell-related clinical trials for the novel coronavirus (SARS-CoV-2) disease COVID-19 continues to spiral upward, mostly in China. During the last two weeks, I’ve been trying to carve out a bit of time to look at these actual trials in more depth, but I admittedly haven’t gotten

‘We Cannot Stick to the Rules’: claims of stem cells saving COVID-19 patients Read More »

COVID-19

As clinics buzz about coronavirus, COVID19 patient given non-FDA-approved exosomes?

Recommended regenerative medicine reads plus COVID-19 stem cell hype

Patient Q&A#2: Are autoimmune or stem cell transplant patients at higher risk from COVID-19?

Athersys & Mesoblast stem cells for COVID-19?

‘We Cannot Stick to the Rules’: claims of stem cells saving COVID-19 patients

Subscribe to Our Newsletter